[go: up one dir, main page]

AU2002354848A1 - Liquid formulation comprising Cetuximab and a fatty acid ester of polyoxyethylene sorbitan - Google Patents

Liquid formulation comprising Cetuximab and a fatty acid ester of polyoxyethylene sorbitan

Info

Publication number
AU2002354848A1
AU2002354848A1 AU2002354848A AU2002354848A AU2002354848A1 AU 2002354848 A1 AU2002354848 A1 AU 2002354848A1 AU 2002354848 A AU2002354848 A AU 2002354848A AU 2002354848 A AU2002354848 A AU 2002354848A AU 2002354848 A1 AU2002354848 A1 AU 2002354848A1
Authority
AU
Australia
Prior art keywords
cetuximab
fatty acid
acid ester
polyoxyethylene sorbitan
liquid formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002354848A
Inventor
Christiane Bachmann
Udo Haas
Hanns-Christian Mahler
Ulrike Martini-Marr
Robert Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU2002354848A1 publication Critical patent/AU2002354848A1/en
Abandoned legal-status Critical Current

Links

AU2002354848A 2001-07-13 2002-06-18 Liquid formulation comprising Cetuximab and a fatty acid ester of polyoxyethylene sorbitan Abandoned AU2002354848A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10133394.3 2001-07-13

Publications (1)

Publication Number Publication Date
AU2002354848A1 true AU2002354848A1 (en) 2003-03-03

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002240400A1 (en) Free-standing baking receptacle and methods of use
HUP0401046A3 (en) Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan
AUPR510001A0 (en) Formulation and method
AU2002239286A1 (en) Display device and methods of manufacture and control
AU2001294920A1 (en) Chrono delivery formulations and method of use thereof
AU3591301A (en) Ester derivatives of dimethylpropionic acid and pharmacetuical compositions containing them
AU2002246608A1 (en) Compositions containing heteropolymers and oil-soluble esters and methods of using same
AU2000278326A1 (en) Interactive and animated mini-theater and method of use
AU2003223930A1 (en) Pharmaceutical use of boronic acids and esters thereof
AU2003239919A1 (en) Intravenous rifalazil formulation and methods of use thereof
EP1228974A3 (en) Liquid dispensing package and method of manufacture
AU2003222083A1 (en) Acid and ester compounds and methods of using the same
AU2003225651A1 (en) Nematicidal fatty acid and fatty acid ester related compounds
AU2058701A (en) Esters of vitamin D3 and uses thereof
AU2002346923A1 (en) Inhibitor mixture for (meth)acrylic acid and (meth)acrylic acid ester
AU2002315225A1 (en) Fastener remover and method of use
AU2003246394A1 (en) Preparations containing diformates and short-chain carboxylic acids
AU2000238612A1 (en) Point of sale display
AU2001280646A1 (en) Display and method of manufacture
AU2002308979A1 (en) Acrylic esters and use thereof
AU2002228711A1 (en) Hydroxy-alkanoic acid ester monomer compositions and methods of making same
EP1578348A3 (en) Formulation comprising bioactive agents and method of using same
AU2002246926A1 (en) 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof
AU2002354848A1 (en) Liquid formulation comprising Cetuximab and a fatty acid ester of polyoxyethylene sorbitan
AU2001261837A1 (en) Automatic configuration of equipment and software